Drug
H Pylori Treatment
H Pylori Treatment: highest development phase Phase 2/3, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| H. pylori treatment NCT00202488 | Phase 2/3 | Iron Deficiency Anemia |
Latest
No recent events.
Follow H Pylori Treatment on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.